Skip to main content
. Author manuscript; available in PMC: 2009 Jun 11.
Published in final edited form as: Hum Reprod. 2006 Aug 12;22(1):36–44. doi: 10.1093/humrep/del328

Figure 5.

Figure 5

Confocal immunofluorescent localization of E-series prostanoid-2 (EP2) receptor and fibroblast growth factor 2 (FGF2) in endometrial adenocarcinoma. Localization of the site of expression of the EP2 receptor (red; left panel), FGF2 (green; central panel) and co-localization of EP2 receptor and FGF2 (merged yellow; right panel) in human endometrial adenocarcinoma. P, poorly differentiated; M, moderately differentiated and W, well-differentiated adenocarcinomas; inset, negative control section.